GlassScriptPhysician profile
Kathleen M Pollock
NPI 1073519559
$1,785.68
in general payments reported to CMS, 2019-2025
19 companies · $624 in 2025
The $624 reported for 2025 was more than what 85% of Obstetrics & Gynecology providers received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $124 · 2020: $32.22 · 2022: $434 · 2023: $414 · 2024: $158 · 2025: $624.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,196.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,195.51 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astellas Pharma US INC | $216.84 | 2019-2025 | Veozah |
| Siemens Medical Solutions USA, INC. | $214.48 | 2023-2025 | Embozene, Microthermx Microwave Ablation System, Oncozene |
| Biogen, INC. | $202.87 | 2024-2025 | Zurzuvae |
| Abbvie INC. | $156.37 | 2019-2023 | |
| Janssen Pharmaceuticals, INC | $143.75 | 2025 | Spravato |
| Aspira Women'S Health INC | $122.81 | 2022 | |
| Bayer Healthcare Pharmaceuticals INC. | $110.59 | 2019-2025 | |
| Hologic Sales and Service, LLC | $103.11 | 2019-2025 | Aptima |
| Daiichi Sankyo INC. | $101.65 | 2022 | |
| Exeltis, USA INC. | $97.96 | 2022-2025 | Slynd |
| Mayne Pharma Commercial LLC | $92.55 | 2022-2025 | |
| Shield Therapeutics INC | $53.27 | 2022 | |
| Organon LLC | $39.58 | 2023 | Nexplanon |
| Exact Sciences Corporation | $33.85 | 2025 | Cologuard Collection Kit |
| Sumitomo Pharma America, INC. | $25.11 | 2025 | Myfembree |
Show all 19 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Millicent US INC | $22.36 | 2025 | Intrarosa |
| Myriad Genetic Laboratories, INC. | $17.16 | 2023 | Myrisk |
| Mycovia Pharmaceuticals, INC. | $16.12 | 2022 | |
| Coopersurgical, INC. | $15.25 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Kathleen Pollock listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.